Story

Rentokil Initial Stock Hits 52-Week Low After Morgan Stanley Downgrade

ENTHMSVIIDZHZH-TWJAKOHI
Sep 29, 20262 min read
Rentokil Initial Stock Hits 52-Week Low After Morgan Stanley Downgrade

Summary

Rentokil Initial's American Depositary Receipts fell over 3% to a new 52-week low after Morgan Stanley downgraded the stock, citing intensifying competition in the U.S. pest control market.

Text size
Background

American Depositary Receipts of Rentokil Initial PLC (NYSE: RTO) fell more than 3% in morning trading to a new 52-week low, after Morgan Stanley downgraded the pest control giant, citing intensifying competition in the U.S. market. The stock dropped 3.1% to $19.86 per share.

Analyst Downgrade Details

Morgan Stanley lowered its rating on Rentokil's stock to "Equal Weight" from a previous "Overweight" designation, according to a note from the bank. The firm also slashed its price target on the London-listed shares by 16% to GBP 4.20 from GBP 5.00.

The bank pointed to two primary drivers for the downgrade:

  • Intensifying competitive pressure in the U.S. pest control market.
  • Compressed valuation multiples across the peer group.

In a notable contrast, Morgan Stanley maintained its "Overweight" rating on Rentokil's chief rival, Rollins Inc. (NYSE: ROL), underscoring a preference for the competitor at this time.

Sample IUX Markets – In-articleAd

Competitive Headwinds in the US

The analyst note highlighted the rapid expansion of private equity-backed operators within the U.S. pest control sector, a key growth market for Rentokil. According to Morgan Stanley, these firms now represent more than 16% of revenue among the top 100 U.S. pest control companies, a significant increase from just 1% a decade ago. The bank expects this trend to continue squeezing established players.

Morgan Stanley also stated it does not expect Rentokil to return to its prior premium earnings multiple and anticipates a weak third-quarter report, noting that a turnaround under the new chief executive will likely be a lengthy process.

Broader Context and Investor Sentiment

The downgrade exacerbates an already challenging period for Rentokil investors, with the stock having lost over 30% of its value since June. Investor confidence was previously shaken by the company's decision to withdraw its 20% margin target for North America for 2027. The source material also noted a decline in hedge fund ownership in the most recent quarter, falling from 19 portfolios to 15. A weaker U.S. equity market on the day provided no support for the stock.

Read next

More on Stocks
Back to latest news

LATEST